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1.1. A nanomolar-potency small molecule inhibitor of STAT5
Disruption of the JAK–STAT signaling pathway is responsible for
a number of hemopoietic malignancies, and thus has been targeted
with numerous inhibitors for therapeutic beneﬁt. In particular, pro-
grams have attempted to ﬁnd upstream kinase inhibitors, but poor
target selectivity or cardiovascular toxicity has limited the impact
of this approach. An alternative strategy is to target the down-
stream Signal Transducer and Activator of Transcription (STAT) 5
protein. The activation of STAT5 is usually highly regulated by cyto-
kines and growth factors. Binding of extracellular cytokines to their
receptors induces activation of receptor-associated JAK kinases,
which in turn by phosphorylation provides binding sites for the
SRC homology 2 (SH2) domains of inactive STAT5 monomers. Phos-
phorylation of STAT5 results in dimerization, and these protein di-
mers translocate to the nucleus to initiate transcription of genes





















A recent paper describes the use of in silico modeling and a li-
brary of analogues to ﬁnd a nanomolar inhibitor of the STAT5 pro-
tein [1]. The authors had previously described phosphopeptide-
mimicking salicylic acid compounds (1 and 2) that targeted the
SH2 domain of STAT3. Screening these compounds against STAT5
revealed weak activity, providing a starting point for a STAT5
inhibitor approach.
Compound 2 exhibited greater potency against STAT5 and com-
parison with compound 1 suggested some structural variability be-
tween the SH2 domains of STAT3 and STAT5 that could support a
computational docking approach. In particular, it appeared that
STAT5 preferred a smaller substituent on the amide nitrogen, and
this led to the design of a small library of analogues to investigatehttp://dx.doi.org/10.1016/j.comche.2014.12.001
E-mail: nterrett@ensembletx.comthis region of the molecule. 24 compounds were prepared explor-
ing variation of the R1 group in two related series that exhibited a



































The compounds were assessed for their ability to disrupt the phos-
phopeptide–STAT5B SH2 domain interactions. Of the analogues
made, it was found that there was a preference for aromatic deriv-
atives in the R1 position. Further in silico work indicated a STAT5
preference for electron-deﬁcient substituents on the sulfonamide
nitrogen, and a small number of compounds were prepared pre-
senting a 4-chlorobenzyl substituent in this position. Of these,
compound 4 was a nanomolar binding inhibitor of STAT5 and
1000-fold selective over STAT3. With no off-target kinase afﬁnity,
compound 4 offers a probe for interrogating STAT5 function in dis-
eased cells.
2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
The guanidinylation of a peptide chain on a polymeric support
under microwave conditions, using S-alkylisothioureas, pyrazole-
carboxamidine, andguanidine as guanidinylating reagents, has been
described. The best results were obtained with N,N0-di-benzyloxy-
carbonyl-S-methylisothiourea and N,N0-di-(2-chlorobenzyloxycar-
bonyl)-S-methylisothiourea, as it was found that guanidinylation
with reagents containing Boc groupswas accompanied by side reac-
tions [2].
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The synthesis of a library of over 20, mainly aryl or heteroaryl,
N-methyliminodiacetic acid (MIDA) boronates has been reported.
A rapid microwave-mediated method (5–10 min) has been devel-
oped using polyethylene glycol 300 as solvent, although acetoni-
trile and dimethylformamide were found to be suitable
alternative solvents [3].
An efﬁcient and ﬂexible strategy toward the synthesis of a li-
brary of biologically and pharmaceutically important tetracyclic
heteroazulene derivatives has been described. The strategy in-
volves a sequential alkylation and alkenylation of indole/benzofu-
ran/benzothiophene with o-alkynyl benzyl alcohol derivatives to
obtain tetracyclic heteroazulene derivatives in moderate to good
yields. Overall, the present strategy is general, versatile, and envi-
ronmentally friendly [4].
2.3. Scaffolds and synthons for combinatorial libraries
Using 2,8-bis(triﬂuoromethyl)quinoline, the pharmacophore of
meﬂoquine, as a central scaffold, eleven novel triazole-linked com-
pounds have been synthesized by the application of CuAAC chem-
istry. The in vitro biological activity of the compounds on the
Plasmodium falciparum chloroquine-sensitive strain NF54 was then
determined. The compounds all showed IC50s in the lower lM
range with (1R,3S,5R)-N-{[1-(2,8-bis(triﬂuoromethyl)quinoline-4-
yl)-1H-1,2,3-triazol-4-yl]methyl}adamantan-2-amine exhibiting
the best activity [5].
2.4. Solid-phase supported reagents
A mesoporous aluminosilicate (Al-MCM-41) has been found to
be an effective heterogeneous catalyst for the reaction of both alde-
hydes and acetals with silyl enol ethers or ketene silyl acetals to
give the corresponding aldol adducts in moderate to high yields.
The high catalytic activity of Al-MCM-41 over amorphous silica–
alumina and aluminum-free mesoporous silicate was observed in
the reaction. The solid acid catalyst could be recovered easily by ﬁl-
tration and was reusable in the same reactions without a signiﬁ-
cant loss of catalytic activity [6].
Polystyrene resin-supported copper (I) iodide-cryptand-22
complex (PS–C22–CuI) has been synthesized and characterized
by FT-IR, EDX, SEM, XPS, and TG-DTA analysis. This complex was
found to be a highly active and robust heterogeneous catalyst for
either three-component reaction of organic halides, sodium azide,
and terminal alkynes, or the reaction of organic azides and alkynes
to form 1,4-disubstituted 1,2,3-triazoles. The reactions proceeded
in good to excellent yields at room temperature using water as
the green solvent [7].
A novel and efﬁcient method for the N-formylation of amines
via the reaction of orthoformates and amines has been developed.
The reactions were mediated by a catalytic amount of molybdate
sulfuric acid as a heterogeneous solid acid [8].
2.5. Novel resins, linkers and techniques
No papers this month
2.6. Library applications
A small library of amino acid ester prodrugs of 6-b-naltrexol has
been prepared in order to investigate the candidacy of these pro-
drugs for microneedle-enhanced transdermal delivery. Six amino
acid ester prodrugs were synthesized, and several were stable en-
ough at skin pH (pH 5.0) to move forward to studies in 50% human
plasma [9].A novel library of Schiff base analogues has been synthesized by
the condensation of methyl-12-aminooctadec-9-enoate and differ-
ent substituted aromatic aldehydes. The synthesized compounds
were thoroughly characterized by spectroscopic techniques and
were screened for in vitro antibacterial activity against seven dif-
ferent bacterial strains. Several were found to exhibit excellent to
good antimicrobial activities (MIC value 9–18 lM) against Staphy-
lococcus aureus MTCC 96, S. aureus MLS-16 MTCC 2940 and Bacillus
subtilis MTCC 121 [10].
A library of twenty-six benzenesulfonylurea-containing thi-
ophenylpyrazoline moieties have been synthesized. All the com-
pounds were docked against PPAR-c target, and most displayed
higher docking scores than the standard drugs, glibenclamide
and rosiglitazone. All the synthesized compounds were evaluated
for their antidiabetic effect by the oral glucose tolerance test, and
further assessment of antidiabetic potential was undertaken using
the STZ-induced diabetic model. Results from in vivo studies by
both methods were found to be consistent with the docking study
data [11].
In an effort to identify novel cholinesterase candidates for the
treatment of Alzheimer’s disease, a diverse array of potentially bio-
active compounds were obtained in good yields through the cyclo-
condensation reaction of 4-amino-5-(pyridin-3-yl)-4H-1,2,4-
triazole-3-thiol with various substituted aryl/heteroaryl/aryloxy
acids and phenacyl bromides. The structures of newly prepared
compounds were conﬁrmed by IR, 1H and 13C NMR spectroscopy.
The newly synthesized heterocycles were screened for cholinester-
ase inhibitory activity against electric eel acetylcholinesterase
(EeAChE) and horse serum butyrylcholinesterase (hBChE), and sev-
eral compounds were identiﬁed as potent inhibitors [12].
Chikungunya virus (CHIKV), a mosquito-borne arthrogenic
Alphavirus, causes an acute febrile illness in humans accompanied
by severe joint pains. No drugs have been approved or are in devel-
opment for the treatment of CHIKV, which makes this viral infec-
tion particularly interesting for academic medicinal chemistry
efforts. Several molecules have already been identiﬁed that inhibit
CHIKV replication in phenotypic virus-cell-based assays. One of
these is Arbidol, a molecule that has been licensed for the treat-
ment of inﬂuenza A and B virus infections. For structural optimiza-
tion, a dedicated library of 43 indole-based derivatives was
evaluated leading to more potent analogues with anti-CHIKV activ-
ities [13].
A library consisting of some novel glitazones has been pre-
pared. These compounds contained the thiazolidinedione ring
structure or its bioisosteres, rhodanine or oxadiazolidine, as
the central scaffold, and were investigated for their antidiabetic
activity. Twelve novel glitazones with diverse chemical struc-
tures were designed, synthesized and proﬁled, and several
exhibited glucose uptake activity ranging from weak to signiﬁ-
cant activity [14].
A library of structurally diverse Tröger’s base analogues has
been constructed via an unusual amination of methylene bridge
under Vilsmeier–Haack conditions. The structurally diverse frame-
works were evaluated for their cytotoxic activities against a panel
of three human cancer lines: A549 (lung adenocarcinoma),
MDAMB-231 (breast) and SK-N-SH (neuroblastoma). From the
activity proﬁle obtained, a redesign of the analogues led to the con-
struction of more potent molecular entities, and the development
of compounds with MDAMB-231 cell line speciﬁc cytotoxicity [15].
A novel series of 3,6-diazabicyclo[3.1.1]heptane-3-carboxam-
ides, targeting both the a4b2 and a6/a3b2b3 nicotinic acetylcho-
line receptors have been prepared. Members of this chemical
library are partial or full agonists at both receptors. One key com-
pound demonstrated a safe in vitro pharmacological proﬁle and po-
tential for reducing or preventing L-dopa-induced dyskinesias in
several in vivo animal models [16].
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investigated to detect the amyloid b-protein (Ab) aggregates by
magnetic resonance imaging (MRI) to permit early diagnosis of Alz-
heimer’s disease. A building block strategy has been used to synthe-
size a library of 16 CAs to investigate structure–activity
relationships (SARs) on physicochemical properties and binding
afﬁnity for the Ab aggregates. Three types of blocks were used to
modulate the CA structures: (i) Gd(III) chelates, (ii) biovectors (2-
arylbenzothiazole, 2-arylbenzoxazole and stilbene derivatives)
and (iii) linkers (neutrals, positives and negatives with several
lengths). These investigations revealed unexpected SARs and pro-
vided general insights for thedevelopment ofGd(III)-basedCAs [17].
A library of novel 1,3,4-oxadiazole and 2-4-thiazolidinedione
based bis-heterocycles has been synthesized and these compounds
exhibited signiﬁcant PPAR-c transactivation and blood glucose-
lowering effect comparable with the standard drugs pioglitazone
and rosiglitazone. Two of the compounds may be considered as po-
tential candidates for development of new antidiabetic agents [18].
The design and synthesis of protein tyrosine phosphatases-1B
(PTP1B) inhibitors are important for the drugs targeted to treat dia-
betes and obesity. Ten prioritized compounds from the library of
86 structures were synthesized and found positive in the micromo-
lar range in PTP1B in vitro inhibitory assays. Five active compounds
were tested in streptozotocin-induced diabetic rat model and the
most active compound found was further proﬁled in diabetic and
pharmacokinetic models [19].
Following a report that 1-(1,4-dioxaspiro[4,5]dec-2-ylmethyl)-
4-(2-methoxyphenyl)piperazine is a highly selective and potent
5-HT1AR ligand, a parallel synthetic strategy has been explored
around this structure. The compounds were tested for binding
afﬁnity and functional activity at 5-HT1AR and a<alpha>1-adreno-
ceptor subtypes. Several compounds emerged as promising a<al-
pha>1 receptor antagonists, and may represent a new starting
point for developing more selective ligands [20].References
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